We are pleased to invite investors and analysts to participate in a live video webcast and conference call on Monday, 27 July, 2020, highlighting Roche data accepted for presentation via the ASRS 2020 Virtual Scientific Program July 24-26, 2020.
16:30 - 17:30 CEST / 15:30 - 16:30 BST
10:30 - 11:30 am EDT / 7:30 - 8:30 am PDT
Video webcast and conference call will start with a presentation, followed by a Q&A session (live access to the speakers).
Access to video webcast and conference call
Dial in details will soon follow.
A replay of the webcast will be available via >ir.roche.com
*privacy notice
Best regards, | |
Karl Mahler Head of Investor Relations and Roche Group Planning |
Lisa Tuomi Investor Relations Officer |
Roche Investor Relations | |
Dr. Karl Mahler Phone: +41 61 68-78503 e-mail: karl.mahler@roche.com |
Dr. Sabine Borngräber Phone: +41 61 68-88027 e-mail: sabine.borngraeber@roche.com |
Dr. Bruno Eschli Phone: +41 61 68-75284 e-mail: bruno.eschli@roche.com |
Dr. Birgit Masjost Phone: +41 61 68-84814 e-mail: birgit.masjost@roche.com |
Dr. Gerard Tobin Phone: +41 61 68-72942 e-mail: gerard.tobin@roche.com |
Jon Kaspar Bayard Phone: +41 61 68-83894 e-mail: jon_kaspar.bayard@roche.com |
Investor Relations North America | |
Loren Kalm Phone: +1 650 225 3217 e-mail: kalm.loren@gene.com |
Dr. Lisa Tuomi Phone: +1 650 467 8737 e-mail: tuomi.lisa@gene.com |
Attachment
- Invitation_ASRS_2020_V4
Attachments
- Original document
- Permalink
Disclaimer
Roche Holding AG published this content on 01 July 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 01 July 2020 08:03:00 UTC